Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation

Autor: Karine E. Manera, John S. Gill, Germaine Wong, Allison Tong, John Kanellis, Lionel Rostaing, Rainer Oberbauer, Bénédicte Sautenet, Nicholas B Cross, Timothy L. Pruett, Jeremy R. Chapman, Tasleem Rajan, Klemens Budde, Simon R. Knight, Helen Tam-Tham, Lorna Marson, Sreedhar Mandayam, Stephen P. McDonald, David Rosenbloom, Jonathan C. Craig, Kirsten Howard, Samuel Fung, Nicole Evangelidis, Jean-Michel Halimi, Michelle A. Josephson, Donal O'Donoghue, Anthony N. Warrens, Peter P. Reese, Martin Howell, Shilpa Jesudason, Jenny I. Shen, Philip Masson, John D. Scandling, Camilla S. Hanson, Steve Chadban
Přispěvatelé: MethodS in Patients-centered outcomes and HEalth ResEarch (SPHERE), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR des Sciences Pharmaceutiques et Biologiques, Université de Nantes (UN)-Université de Nantes (UN), Université de Tours-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR des Sciences Pharmaceutiques et Biologiques
Rok vydání: 2017
Předmět:
Adult
medicine.medical_specialty
Kidney Disease
Consensus
Outcome Assessment
Delphi Technique
Adolescent
Health Personnel
[SDV]Life Sciences [q-bio]
Renal and urogenital
030232 urology & nephrology
Delphi method
MEDLINE
Medical and Health Sciences
Outcome (game theory)
Young Adult
03 medical and health sciences
0302 clinical medicine
Clinical Research
Surveys and Questionnaires
Behavioral and Social Science
Health care
Journal Article
medicine
Humans
030212 general & internal medicine
Young adult
Kidney transplantation
Aged
Clinical Trials as Topic
Transplantation
Health professionals
business.industry
Organ Transplantation
Middle Aged
medicine.disease
Kidney Transplantation
3. Good health
Health Care
Good Health and Well Being
Caregivers
Multinational corporation
Family medicine
Surgery
business
Zdroj: Sautenet, B, Tong, A, Manera, K E, Chapman, J R, Warrens, A N, Rosenbloom, D, Wong, G, Gill, J, Budde, K, Rostaing, L, Marson, L, Josephson, M A, Reese, P P, Pruett, T L, Hanson, C S, O'Donoghue, D, Tam-Tham, H, Halimi, J-M, Shen, J I, Kanellis, J, Scandling, J D, Howard, K, Howell, M, Cross, N, Evangelidis, N, Masson, P, Oberbauer, R, Fung, S, Jesudason, S, Knight, S, Mandayam, S, McDonald, S P, Chadban, S, Rajan, T & Craig, J C 2017, ' Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation : A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals ', Transplantation, vol. 101, no. 8, pp. 1875-1886 . https://doi.org/10.1097/TP.0000000000001776
Transplantation
Transplantation, 2017, 101 (8), pp.1875-1886. ⟨10.1097/TP.0000000000001776⟩
Transplantation, vol 101, iss 8
ISSN: 0041-1337
DOI: 10.1097/tp.0000000000001776
Popis: Background: Inconsistencies in outcome reporting and frequent omission of patient-centered outcomes can diminish the value of trials in treatment decision-making. We identified critically important outcome domains in kidney transplantation based on the shared priorities of patients/caregivers and health professionals. Methods: In a 3-round Delphi survey, patients/caregivers and health professionals rated the importance of outcome domains for trials in kidney transplantation on a 9-point Likert scale and provided comments. During Round 2 and 3, participants re-rated the outcomes after reviewing their own score, the distribution of the respondents’ scores, and comments. We calculated the median, mean, and proportion rating 7-9 (critically important), and analyzed comments thematically. Results: 1018 participants (461 [45%] patients/caregivers and 557 [55%] health professionals) from 79 countries completed Round 1, and 779 (77%) completed Round 3. The top eight outcomes that met the consensus criteria in Round 3 (mean ≥7.5, median ≥8 and proportion >85%) in both groups were graft loss, graft function, chronic rejection, acute rejection, mortality, infection, cancer (excluding skin) and cardiovascular disease. Compared with health professionals, patients/caregivers gave higher priority to six outcomes (mean difference of 0.5 or more): skin cancer, surgical complications, cognition, blood pressure, depression, and ability to work. We identified five themes: capacity to control and inevitability, personal relevance, debilitating repercussions, gaining awareness of risks, and addressing knowledge gaps. Conclusions: Graft complications and severe comorbidities were critically important for both stakeholder groups. These stakeholder-prioritized outcomes will inform the core outcome set to improve the consistency and relevance of trials in kidney transplantation.
Databáze: OpenAIRE